Go to navigation Go to content
Toll-Free: 888-526-7616
Phone: 713-523-0001

Types of Errors

Dangerous and Defective Drugs If you put your trust in a pharmaceutical company and were hurt by their product, you deserve compensation for your suffering.
Wrong Medication Did you receive the wrong medication or incorrect prescription from a pharmacy? If you have suffered because of a medication error please call us for a free case review.
Wrong Dosage Common forms of medication error: incorrect dosage error. Order our free book to learn how to protect yourself and your family from wrong dosage errors.
Other Errors Order our free book, "How to Make Pharmacies Pay for your Injuries Caused by Medication Errors, to learn your rights in prescription error cases.
Kids Rx Errors Order a free copy of The Top 10 Tips to Protect Your Children Against Pharmacy Errors. If you have suffered a prescription error contact our firm today.
Pharmacy Malpractice If you have suffered an injury because a pharmacy dispensed the wrong medication or made an error with your prescription, you are able to file a claim for negligence or malpractice and receive the compensation you deserve.
Walgreens Pharmacy Error Claims There have been numerous claims brought against Walgreens for pharmacy errors or prescription errors. Order our free book to learn how to take action.
CVS Pharmacy Error Claims If you've been injured because of a CVS Pharmacy prescription error, call us for help with your lawsuit at 888-526-7616.
State Pharmacy Boards If you have been severely injured because of a medication error, contact board-certified attorneys immediately to investigate your case free of charge.
Drug & Pharmacy Error Prevention Filing a pharmacy error lawsuit is the only way to make pharmacies take accountability for mistakes. Call our board certified attorneys for a free case review.
State Pharmacy Laws State laws on pharmacy malpractice. Learn the pharmacy error Statute of Limitation laws that apply to your state. Call 877-342-2020 for a free consultation.

Reducing Drug Label Confusion Reduces Harm to Consumers

Galvin B. Kennedy
Connect with me
Partner at Kennedy Hodges LLP practicing personal injury, pharmacy error, and overtime law
Posted on Mar 05, 2014

Did you know that 33 percent of medication errors that occur in this nation are the result of problematic labels, packaging, and names? According to the Institute of Medicine, even fatalities have occurred from poor packaging and container labels.

The reality is that too many drugs have similar names, labels, designs, and look or sound similar that it can be confusing and lead to medication errors. As a result, the FDA issued new guidelines in December 2012 for drug manufacturers to abide by that will improve the way medications are packaged and labeled. In fact, many drug manufacturers have already stopped making similar designs to other products and have started prioritizing the information on the labels.

The drug label should now state the quantity of the drug per total volume before listing the per milliliter concentration. Before this change was made, people overdosed on heparin and other medications. Additionally, confusing packaging on other drug containers caused injuries to consumers. For example, many people ingested topical Benadryl that caused them to hallucinate because they didn’t see the small letters that read “Topical Analgesic.” Now, Benadryl maker Johnson & Johnson added a sticker with large type on the cap that reads “For Skin Use Only.”

Consumers aren’t the only ones who have mistaken one drug for another or who have been confused by packaging. Sometimes pharmacists have had a hard time recognizing the difference between similar drug names. As a result, drugs have been mistaken for others.

Because of the seriousness that drug labels and similar drug names can have on consumers’ health, it is critical that manufacturers do their part to prevent medication errors. This is why the FDA has focused their efforts on having manufacturers design better packaging and labels. Still to come, the FDA will release its final recommendation to drug manufacturers this year that will focus on how proprietary drugs are named.